Cellular Engineering Technologies Receives Exclusivity to Use John Paul II Medical Research Institute's Immortalized Human Stem Cells for Commercial Bio-Production Applications.

March 6, 2023

​

​

The USPTO Issues a Patent to Cellular Engineering Technologies for Producing a Safer Induced Pluripotent Stem Cell.

March 8, 2022

​

​

Cellular Engineering Technologies Enter CRISPR/Cas9 License Agreement​.

August 17, 2021

​

​

Cellular Engineering Technologies has Been Awarded a Phase 2 Small Business Innovation Research (SBIR) Grant from the National Institutes of Health to Improve Reproducible and Safer Pluripotent Stem Cells.

August 14, 2020

​

​

Cellular Engineering Technologies, the John Paul II Medical Research Institute and the University of Iowa Create the First Virus-Free and Oncogene-Free Induced Pluripotent Stem Cell (iPSC) Technology to Produce Safer Pluripotent Stem Cells from Cord Blood and Peripheral Blood.

November 30, 2018

​

​

CET Has Been Rewarded A Sole Source Navy Contract for Human Amniotic Mesenchymal Stem Cells.

November 3, 2017

​

​

Cellular Engineering Technologies and the John Paul II Medical Research Institute Report New Approach to Create Myc and Lin28-Free Induced Pluripotent Stem Cells.

May 12, 2017

​

​

Cutting Edge Cancer Technology

KGAN-TV CBS2 News Iowa, June 2014

​

​

Iowa Organizations Join Forces to Offer Cutting-Edge Personalized Cancer Diagnosis and Treatment to Patients.

May 2014

 

 

CET Announcing Products for iPS Cell Lines.

January 2013

 

 

CET Announces New Stem Cell Biobank Partnership to Accelerate Drug Discovery.

January 2013

 

 

CET now provides customize induced pluripotent stem (iPS) cell reprograming service and products.

October 2012

 

 

Cellular Engineering Technologies, Inc. (CET) now offers patients-specific Human Bronchial Epithelial cells.

May 2012

 

 

Cellular Engineering Technologies, Inc. (CET) now offers Human

Foreskin Fibroblast (HFF) and Keratinocyte cells.

May 2012

 

 

Federal Grant to Fund Acceleration of New Treatments for Rare

Orphan Diseases.

November 2010

 

 

CET Announces An NIH Intramalls Vendor.

September 2010

 

 

CET Announces A Comprehensive Product Line.

May 2010

 

 

Cellular Engineering Technology Receives DEMO Fund Grant from the Iowa Department of Economic Development (IDED) to Develop Novel Induced Pluripotent Stem Cells.

March 2010

 

 

Cellular Engineering Technologies Inc Receives 2009 Best of Business Award From Small Business Commerce Association.

March 2010